abstract |
The use of novel and known lipase-inhibitory compounds of the general formula I, (see formula I) wherein A1, A2, R2 and Z have the meanings given in the description, for the treatment and/or prophylaxis of obesity and also concomitant and/or secondary diseases involved therewith are described. |